(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol,
LX-4211,
LX4211,
sotagliflozin,
Sotagliflozin,
1018899-04-1,
LX-4211,
LX4211,
UNII-6B4ZBS263Y,
Sotagliflozin (LX4211),
6B4ZBS263Y,
MFCD22493506,
LP-802034,
(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol,
b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-;b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-,
beta-l-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, (5S)-,
Sotagliflozin [USAN:INN],
AK170751,
beta-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-,
LX 4211,
sotagliflozin-lx4211,
Tube103,
LP 802034,
Sotagliflozin (USAN/INN),
C21H25ClO5S,
Sotagliflozin (LX-4211),
GTPL8312,
SCHEMBL1038287,
CHEMBL3039507,
DTXSID20144314,
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol,
EX-A1167,
3792AH,
s8103,
ZINC95641922,
AKOS025290846,
ACN-037454,
CM11080,
CS-1069,
DB12713,
SB10646,
4CA-0766,
AC-29890,
AS-35202,
BC600522,
HY-15516,
SC-94335,
AB0165653,
FT-0773701,
D10669,
W-5944,
LX-4211|||LP-802034|||(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol,
D0U7IL,
A12680,